Lanean...
Targeting angiogenesis for liver cancer: Past, present, and future
Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer mortality globally. Most patients were diagnosed at an advanced stage, and systemic therapy is the standard of care. All the approved systemic therapies for HCC are molecular targeted therapies with anti-angio...
Gorde:
| Argitaratua izan da: | Genes Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Chongqing Medical University
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452391/ https://ncbi.nlm.nih.gov/pubmed/32884987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2020.03.010 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|